Détention brevets de la classe A61K 31/09

Brevets de cette classe: 719

Historique des publications depuis 10 ans

62
58
58
56
57
60
51
44
38
28
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Propriétaires principaux

Proprétaire
Total
Cette classe
The University of British Columbia
1520
19
Kaneka Corporation
4600
17
British Columbia Cancer Agency Branch
192
17
Elysium Health, Inc.
73
17
Therapeutic Solutions International, Inc.
52
13
The Johns Hopkins University
5737
11
The Regents of the University of California
20211
10
Bayer HealthCare LLC
1342
9
Hong Kong Baptist University
116
9
Cymabay Therapeutics, Inc.
110
8
Symrise AG
1753
8
RB Health (US) LLC
288
8
The Procter & Gamble Company
21989
7
Peloton Therapeutics, Inc.
39
7
Provincial Health Services Authority
188
7
Unigen, Inc.
111
7
Yissum Research Development Company of The Hebrew University of Jerusalem Ltd.
1345
6
BioMendics, LLC
12
5
Ecole Polytechnique Federale de Lausanne (epfl)
1561
5
Ohio University
366
5
Autres propriétaires 524